Chinook Therapeutics (NASDAQ:KDNY) reported quarterly losses of $(0.69) per share. This is a 84.67 percent increase over losses of $(4.50) per share from the same period last year.
Quarterhill Reports $50M Bought-Deal Public Offering Of Convertible Debentures
Quarterhill Inc. ("Quarterhill" or the "Company") (TSX:QTRH) is pleased to announce that it has entered into a $50 million bought-deal financing (the "Convertible Debenture
